학술논문
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer
Document Type
Article
Author
Galffy, G.; Lugowska, I.; Poddubskaya, E.V.; Cho, B.C.; Ahn, M.-J.; Han, J.-Y.; Su, W.-C.; Hauke, R.J.; Dyar, S.H.; Lee, D.H.; Serwatowski, P.; Estelles, D.L.; Holden, V.R.; Kim, Y.J.; Vladimirov, V.; Horvath, Z.; Ghose, A.; Goldman, A.; di Pietro, A.; Wang, J.; Murphy, D.A.; Alhadab, A.; Laskov, M.
Source
In ESMO Open June 2023 8(3)
Subject
Language
ISSN
2059-7029